Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TIMM9P2 is a pseudogene of the human TIMM9 gene, with the full name “Translocase of inner mitochondrial membrane 9 homolog (yeast) pseudogene 2.” It is present in the human genome (HGNC: 100862727), but unlike TIMM9, it does not produce a functional protein and is not considered a therapeutic target. Pseudogenes like TIMM9P2 arise through gene duplication or retrotransposition events and may share sequence homology with their functional counterparts, though they typically lack coding potential or are not expressed. There is no evidence for TIMM9P2 having a direct role in signaling, metabolism, or disease pathways, nor does it serve any known function as a biomarker or drug target[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Translocase of inner mitochondrial membrane 9 homolog (yeast) pseudogene 2 (TIMM9P2).